Stock Events

Stock Events

Seres Therapeutics (1S90.F) Q2 2026 Earnings

5MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-2.13

-0.32

1.5

3.32

Details

Expected EPS

-1.6043732

Actual EPS

-1.7750512

Surprise EPS

-0.17

Surprise Percent

+10.64%

Description

Seres Therapeutics (1S90.F) has reported earnings of -1.7750512 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.